INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 319 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $58,496,942 | -17.1% | 1,569,545 | -22.4% | 0.28% | -22.1% |
| Q4 2022 | $70,526,995 | -33.3% | 2,021,410 | +7.0% | 0.35% | -27.7% |
| Q3 2022 | $105,712,000 | -8.3% | 1,889,067 | -15.2% | 0.49% | -7.6% |
| Q2 2022 | $115,341,000 | -35.7% | 2,228,383 | -9.7% | 0.53% | -27.2% |
| Q1 2022 | $179,405,000 | -3.9% | 2,468,760 | +56.3% | 0.72% | +34.8% |
| Q4 2021 | $186,764,000 | +8.8% | 1,579,536 | +23.4% | 0.54% | +14.2% |
| Q3 2021 | $171,649,000 | +8.7% | 1,279,531 | +31.2% | 0.47% | -1.7% |
| Q2 2021 | $157,877,000 | – | 975,092 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |